Cyclopharm is an established Australian radiopharmaceutical company servicing the global medical community since 1986.
Cyclopharm is a company in the diagnostic imaging field specialising in lung health. We achieve this positioning through our proprietary medical device and pharmaceutical products under the name of TECHNEGASTM.
TECHNEGASTM has become the industry gold-standard in diagnostic functional lung imaging technology.
We distribute our products in 57 countries throughout the world with over 1500 nuclear medicine departments utilising TECHNEGASTM.
To date, over 4.2 million patient procedures are recorded.
Radiopharmaceutical company, Cyclopharm Limited (ASX: CYC) is pleased to confirm that an independent Data Monitoring Efficacy Committee (DEMC), requested by the USFDA as part of its assessment…
Radiopharmaceutical company, Cyclopharm Limited (ASX:CYC) today announced financial report for the six month period to 30 June 2020, including sales revenue of $5.8 million, in line with previ…